Heres the deal: GLP-1 medications can deliver faster and larger results but often require ongoing use and come with side effects like nausea and high costs (around $1,000$1,500 per month)
A fourth medication, nalmefene, is currently approved by the EMA but not by the FDA [7, 8]
GOLO is not intended to diagnose, treat, prevent or cure any illness or disease
The below chemical properties represent the Retatrutide base (2381089-83-2), whereas most commonly, the acetate is the fully prepared form of Retatrutide (LY3437943) which is the product Modern Peptides offers
We focus on research applications so our products and services are designed to meet the needs of researchers not multiple market segments with different requirements.Quality control includes HPLC testing to verify purity and identity of each batch
GLP-1 therapy is particularly considered in patients with a BMI 35 kg/m or those who would benefit from weight loss